Kyoto, Japan

Sotoo Asakura

This inventor holds 9 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1988-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 100(Granted Patents)


Location History:

  • Ooeni, JP (1988)
  • Kyoto, JP (1989 - 1999)

Company Filing History:


Years Active: 1988-1999

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Sotoo Asakura: Innovator in Pharmaceutical Composition and Aqueous Solutions

Introduction

Sotoo Asakura is a notable inventor based in Kyoto, Japan, recognized for his significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, Asakura's innovations are focused on improving medical treatments through advanced compositions.

Latest Patents

His latest patents showcase his commitment to advancing healthcare. One of the notable inventions is a pharmaceutical emulsion composition that exhibits immunosuppressive activity. This composition, described by specific chemical parameters, is designed to function effectively in an organic solvent. Additionally, he has developed an aqueous liquid composition for external use, which includes a tricyclo compound and a water-soluble solubilizer. This formulation is particularly aimed at enhancing medical treatments.

Career Highlights

Sotoo Asakura currently works at Fujisawa Pharmaceutical Company, Ltd., where he continues to innovate in the pharmaceutical sector. His career reflects a dedication to addressing medical needs through inventive solutions.

Collaborations

In his professional journey, Asakura has collaborated with esteemed colleagues, including Yoshio Murakami and Yasuto Koyama. These partnerships have further enriched his research and development efforts in pharmaceutical innovations.

Conclusion

Sotoo Asakura stands out as a key figure in the pharmaceutical industry, with multiple patents that illustrate his innovative mindset. His contributions not only enhance current medical practices but also pave the way for future advancements in pharmaceuticals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…